Mechanisms of cancer metastasis: involvement of cancer stem cells?
- PMID: 20562805
Mechanisms of cancer metastasis: involvement of cancer stem cells?
Abstract
The leading cause of death from cancer is tumor expansion, which usually leads to dissemination and metastasis of malignant cells. Accumulating evidence suggests growing tumors contain some very rare primitive cells that are mobile and thus endowed with metastatic potential. If these cells survive radio/chemotherapy, they are responsible for tumor re-growth after treatment. In this review, we discuss the origin of these cells, which: 1) are true cancer stem cells (CSCs) that initiate tumor growth and are subsequently responsible for metastatic dissemination; or 2) are derived from transformed tumor cells by the epithelial mesenchymal transition phenomenon. We also address major molecular mechanisms involved in trafficking of these cells during metastasis, paying special attention to the underappreciated side effects of radio/chemotherapy that may induce pro-metastatic environments in various organs. Overall, we envision that the process of pathological metastasis of cancer cells reflects a physiological property of normal SCs for their ability to migrate, as seen during embryogenesis. Finally, we discovered highly migratory, very small embryonic-like SCs that are deposited during development in adult tissues. As we hypothesize, these cells could: 1) give rise to some primitive types of tumors; and 2) may have a direct role in cancer expansion by being involved in tumor angiogenesis and formation of tumor stroma.
Similar articles
-
Chemokines in neuroectodermal development and their potential implication in cancer stem cell-driven metastasis.Semin Cancer Biol. 2009 Apr;19(2):68-75. doi: 10.1016/j.semcancer.2008.11.003. Epub 2008 Nov 25. Semin Cancer Biol. 2009. PMID: 19084599 Review.
-
[Encounter of cancer cells with bone. The significance of cancer stem cells and epithelial-mesenchymal transition in tumor invasion and metastasis].Clin Calcium. 2011 Mar;21(3):411-7. Clin Calcium. 2011. PMID: 21358063 Review. Japanese.
-
Metastasis: inherent vs. acquired phenotype.Med Hypotheses. 2010 May;74(5):874-6. doi: 10.1016/j.mehy.2009.11.023. Epub 2009 Dec 16. Med Hypotheses. 2010. PMID: 20006450
-
[Cancer stem cell].Gan To Kagaku Ryoho. 2007 Nov;34(11):1721-9. Gan To Kagaku Ryoho. 2007. PMID: 18030004 Review. Japanese.
-
Beyond tumorigenesis: cancer stem cells in metastasis.Cell Res. 2007 Jan;17(1):3-14. doi: 10.1038/sj.cr.7310118. Cell Res. 2007. PMID: 17179981 Review.
Cited by
-
Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy.Mol Cancer Res. 2013 Jul;11(7):793-807. doi: 10.1158/1541-7786.MCR-12-0600. Epub 2013 Apr 24. Mol Cancer Res. 2013. PMID: 23615526 Free PMC article.
-
Expression of Cancer Testis Antigens in Colorectal Cancer: New Prognostic and Therapeutic Implications.Dis Markers. 2016;2016:1987505. doi: 10.1155/2016/1987505. Epub 2016 Aug 18. Dis Markers. 2016. PMID: 27635108 Free PMC article.
-
Targeting Wnt pathway in mantle cell lymphoma-initiating cells.J Hematol Oncol. 2015 Jun 6;8:63. doi: 10.1186/s13045-015-0161-1. J Hematol Oncol. 2015. PMID: 26048374 Free PMC article.
-
Extracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells.Mol Cancer. 2015 Nov 24;14:201. doi: 10.1186/s12943-015-0469-z. Mol Cancer. 2015. PMID: 26597723 Free PMC article.
-
Evidence that vitronectin is a potent migration-enhancing factor for cancer cells chaperoned by fibrinogen: a novel view of the metastasis of cancer cells to low-fibrinogen lymphatics and body cavities.Oncotarget. 2016 Oct 25;7(43):69829-69843. doi: 10.18632/oncotarget.12003. Oncotarget. 2016. PMID: 27634880 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials